Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label Study of the Effect of a Long-term Calcineurin Inhibitor-free Maintenance Regimen With CellCept and Sirolimus on Preservation of Renal Function and Prevention of Acute Rejection in Recipients of an Orthotropic Liver Transplant
Conditions
Interventions
mycophenolate mofetil [CellCept]
Tacrolimus
+2 more
Locations
46
United States
Birmingham, Alabama, United States
Phoenix, Arizona, United States
La Jolla, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
San Diego, California, United States
Start Date
August 1, 2005
Primary Completion Date
July 1, 2008
Completion Date
December 1, 2008
Last Updated
August 3, 2010
NCT07233096
NCT06717919
NCT06899867
NCT05237583
NCT06682325
NCT06890234
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions